Simulations Plus Inc is a leading provider of advanced software and consulting services for the pharmaceutical and biotechnology industries
The company specializes in modeling and simulations that aid in drug discovery and development, including pharmacokinetics and pharmacodynamics. By offering powerful tools and platforms, Simulations Plus enables researchers to predict and analyze drug behavior and interactions, ultimately enhancing the efficiency and success rate of developing new therapeutics. Their innovative solutions support various stages of the drug development process, helping clients streamline their research efforts, reduce costs, and bring new medications to market more effectively.
Market sentiment improved as Nasdaq gains record level. S&P 500 and Dow Jones also rose, while some sectors closed negatively. Fear & Greed Index at 48.1.
Shares of Reliance Global Group, Inc. (NASDAQ: RELI) fell sharply in today’s pre-market trading after reporting financial results for the year ended Dec 31, 2023.
Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares.
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.
Companies Reporting Before The Bell • Acuity Brands (NYSE:AYI) is projected to report quarterly earnings at $3.25 per share on revenue of $907.75 million.
